News
Tilt collaborates with MSD on immunotherapy clinical trial
Tilt Biotherapeutics – a clinical-stage biotechnology company developing cancer immunotherapies – has announced that it has signed a second clinical trial collaboration and supply agreement with MSD, a trade name of Merck.